Etropal AD (BUL: ETR)
Health Care · Health Care Equipment & Supplies · BG
€2.62
-1.50% today · -34.5% 1Y
Etropal AD (BUL: ETR) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $14.89M.
Over the last twelve months the share price has lost 34.5%, trading between 2.04 and 2.76.
Tweenvest scores Etropal AD across four factors: quality 54/100, value 69/100, growth 100/100. Its strongest factor is growth.
ETR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.89M
- Revenue (TTM)
- $10.16M
- P/E
- —
- EPS
- -0.07
- Dividend yield
- —
- Beta (5Y)
- 0.00
- 52-week high
- €2.76
- 52-week low
- €2.04
- Avg volume (3M)
- —
- Shares outstanding
- 5.00M
- Employees
- —
- Next earnings
- —
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ImpediMed LimitedASX: IPD | $15.33M | AU$0.01 | +20.00% |
| Pulsenmore Ltd.TASE: PLSM | $15.32M | ₪5.82 | -15.45% |
| HeartSciences Inc.NasdaqCM: HSCS | $15.26M | $3.21 | +0.94% |
| Scandinavian Real Heart AB (Publ)OM: HEART | $15.08M | Skr17.85 | +0.56% |
| IBI Silver Castle LtdTASE: IBIS | $14.89M | ₪24.99 | -20.54% |
| Neurotech International LimitedASX: NTI | $14.66M | AU$0.01 | -10.34% |
| Medicon Hellas S.A.ATSE: MEDIC | $14.35M | €2.90 | -2.68% |
| Sintx Technologies, Inc.NasdaqCM: SINT | $14.06M | $2.12 | +0.47% |
Figures last refreshed Oct 11, 2026.